Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


1 Am J Epidemiol
1 Antimicrob Agents Chemother
2 Clin Infect Dis
3 HIV Med
8 J Acquir Immune Defic Syndr
1 J Clin Immunol
1 J Clin Invest
3 J Infect Dis
1 J Virol
1 Lancet Infect Dis
4 N Engl J Med
1 Nat Med
2 Nature
1 PLoS Comput Biol
17 PLoS One
1 PLoS Pathog
1 Virology


  1. LINDGREN AA, Filipowicz AR, Hattler JB, Kim SO, et al
    Lentiviral infection of proliferating brain macrophages in HIV and simian immunodeficiency virus encephalitis despite sterile alpha motif and histidine-aspartate domain-containing protein 1 expression.
    AIDS. 2018;32:965-974.
    >> Share

  2. OLESEN JS, Jespersen S, Da Silva ZJ, Rodrigues A, et al
    HIV-2 continues to decrease, while HIV-1 is stabilizing in Guinea-Bissau.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001827.
    >> Share

  3. KONG CY, Sigel K, Criss SD, Sheehan DF, et al
    Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ >/= 500: a simulation study.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001818.
    >> Share

  4. GEORGE VK, Pallikkuth S, Pahwa R, de Armas L, et al
    Circulating inflammatory monocytes contribute to impaired influenza vaccine responses in HIV-infected participants.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001821.
    >> Share

  5. MASABA R, Borkowf CB, Girde S, Zeh C, et al
    Adverse fetal and infant outcomes among HIV-infected women who received either NNRTI- or PI-based ART for PMTCT.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001816.
    >> Share

  6. ALMEIDA-BRASIL CC, Moodie EEM, Mclinden T, Hamelin AM, et al
    Medication non-adherence, multi-tablet regimens, and food insecurity are key experiences in the pathway to incomplete HIV suppression.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001822.
    >> Share

  7. JACQUET JM, Peyriere H, Makinson A, Peries M, et al
    Psychoactive substances, alcohol and tobacco consumption in HIV-infected outpatients.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001830.
    >> Share

  8. DEUSCH S, Serrano-Villar S, Rojo D, Martinez-Martinez M, et al
    Effects of HIV, ART and prebiotics on the active fraction of the gut microbiota.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001831.
    >> Share

  9. CUADROS DF, Branscum AJ, Mukandavire Z
    Temporal stability of HIV prevalence in high burden areas regardless of declines in national HIV prevalence in Malawi and Zimbabwe.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001820.
    >> Share

  10. CHAMIE G, Schaffer EM, Ndyabakira A, Emperador DM, et al
    Comparative effectiveness of novel non-monetary incentives to promote HIV testing: a randomized trial.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001833.
    >> Share

  11. DE OLIVEIRA F, Cappy P, Lemee V, Moisan A, et al
    Detection of numerous HIV-1/MO recombinants in France.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001814.
    >> Share

  12. KONERU R, Bimonte-Nelson H, Ciavatta V, Haile W, et al
    Reversing interferon-alpha neurotoxicity in a HIV-associated neurocognitive disorders mouse model.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001836.
    >> Share

  13. DUCLOY C, Su B, Mayr L, Klingler J, et al
    HIV transmission from infected CD4+ T cells to allogenic T and dendritic cells is inhibited by broadly neutralizing antibodies.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001834.
    >> Share

  14. LEYES P, Cofan M, Gonzalez-Cordon A, de Lazzari E, et al
    Increased cholesterol absorption rather than synthesis is involved in boosted protease inhibitor associated hypercholesterolaemia.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001837.
    >> Share

  15. ERON JJ, Orkin C, Gallant J, Molina JM, et al
    A week 48 randomized phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001817.
    >> Share

  16. THADEN JT, Gandhi M, Okochi H, Hurt CB, et al
    Seroconversion on PrEP: a case report with segmental hair analysis for timed adherence determination.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001825.
    >> Share

  17. BULL ME, Mitchell C, Soria J, Styrchak S, et al
    Monotypic low-level HIV viremias during ART are associated with disproportionate production of X4 virions and systemic immune activation.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001824.
    >> Share

    Am J Epidemiol

  18. LESKO CR, Keil AP, Moore RD, Chander G, et al
    Measurement of Current Substance Use in a Cohort of HIV-infected Persons in Continuity HIV Care, 2007-2015.
    Am J Epidemiol. 2018 Apr 26. pii: 4986741. doi: 10.1093.
    >> Share

    Antimicrob Agents Chemother

  19. STADER F, Kinvig H, Battegay M, Khoo S, et al
    Analysis of clinical drug-drug interaction data to predict uncharacterized interaction magnitudes between antiretroviral drugs and co-medications.
    Antimicrob Agents Chemother. 2018 Apr 23. pii: AAC.00717.
    >> Share

    Clin Infect Dis

  20. SANFORD R, Ances BM, Meyerhoff DJ, Price RW, et al
    Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary HIV Infection.
    Clin Infect Dis. 2018 Apr 24. pii: 4984654. doi: 10.1093.
    >> Share

  21. NOVAK RM, Ghanem A, Hart R, Ward D, et al
    Risk factors and incidence of syphilis in HIV-infected persons, the HIV Outpatient Study, 1999-2015.
    Clin Infect Dis. 2018 Apr 24. pii: 4982945. doi: 10.1093.
    >> Share

    HIV Med

  22. JIAMSAKUL A, Yunihastuti E, Van Nguyen K, Merati TP, et al
    Mortality following diagnosis of tuberculosis in HIV-infected patients in Asia.
    HIV Med. 2018 Apr 23. doi: 10.1111/hiv.12621.
    >> Share

  23. MASIA M, Padilla S, Garcia JA, Bernardino JI, et al
    Decreasing rates of acute myocardial infarction in people living with HIV: a nationwide cohort study in Spain, 2004-2015.
    HIV Med. 2018 Apr 23. doi: 10.1111/hiv.12616.
    >> Share

  24. CRESSWELL FV, Ellis J, Hartley J, Sabin CA, et al
    A systematic review of risk of HIV transmission through biting or spitting: implications for policy.
    HIV Med. 2018 Apr 23. doi: 10.1111/hiv.12625.
    >> Share

    J Acquir Immune Defic Syndr

  25. SIFUNA P, Otieno L, Andagalu B, Oyieko J, et al
    A Spatial- Temporal Analysis of Hiv-Associated Mortality in Rural Western Kenya 2011-2015.
    J Acquir Immune Defic Syndr. 2018 Apr 20. doi: 10.1097/QAI.0000000000001710.
    >> Share

  26. KATZ DA, Golden MR, Hughes JP, Farquhar C, et al
    HIV Self-Testing Increases HIV Testing Frequency in High Risk Men Who Have Sex with Men: A Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2018 Apr 24. doi: 10.1097/QAI.0000000000001709.
    >> Share

  27. MONROE AK, Myint L, Rutstein R, Aberg J, et al
    Factors Associated with Gaps in Medicaid Enrollment among People with HIV and the Effect of Gaps on Viral Suppression.
    J Acquir Immune Defic Syndr. 2018 Apr 24. doi: 10.1097/QAI.0000000000001702.
    >> Share

  28. PERUMAL R, Abdelghani N, Naidu N, Yende-Zuma N, et al
    The risk of nephrotoxicity in patients with drug-resistant tuberculosis treated with kanamycin/capreomycin with or without concomitant use of tenofovir-containing antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2018 Apr 20. doi: 10.1097/QAI.0000000000001705.
    >> Share

  29. AGOT K, Masters SH, Wango GN, Thirumurthy H, et al
    Can Women Safely Distribute HIV Oral Self-Test Kits to Their Sexual Partners? Results from a Pilot Study in Kenya.
    J Acquir Immune Defic Syndr. 2018 Apr 20. doi: 10.1097/QAI.0000000000001708.
    >> Share

  30. NORTH CM, Muyanja D, Kakuhikire B, Tsai AC, et al
    Systemic Inflammation, Immune Activation and Impaired Lung Function among People Living with HIV in Rural Uganda.
    J Acquir Immune Defic Syndr. 2018 Apr 20. doi: 10.1097/QAI.0000000000001711.
    >> Share

  31. LOGIE CH, Wang Y, Marcus NL, Levermore K, et al
    Pathways from sexual stigma to inconsistent condom use and condom breakage and slippage among men who have sex with men in Jamaica.
    J Acquir Immune Defic Syndr. 2018 Apr 24. doi: 10.1097/QAI.0000000000001712.
    >> Share

  32. KHURANA N, Yaylali E, Farnham PG, Hicks KA, et al
    Impact of Improved HIV Care and Treatment on PrEP Effectivenesss in the United States, 2016-2020.
    J Acquir Immune Defic Syndr. 2018 Apr 20. doi: 10.1097/QAI.0000000000001707.
    >> Share

    J Clin Immunol

  33. KOIZUMI Y, Imadome KI, Ota Y, Minamiguchi H, et al
    Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis.
    J Clin Immunol. 2018 Apr 23. pii: 10.1007/s10875-018-0500.
    >> Share

    J Clin Invest

    Tandem bispecific broadly neutralizing antibody - a novel approach to HIV-1 treatment.
    J Clin Invest. 2018 Apr 23. pii: 121078. doi: 10.1172/JCI121078.
    >> Share

    J Infect Dis

  35. COLBY DJ, Posuwan N, Kroon E, Phanuphak N, et al
    Reply to Chen et al.
    J Infect Dis. 2018 Apr 23. pii: 4982816. doi: 10.1093.
    >> Share

  36. KOSTAKI EG, Nikolopoulos GK, Pavlitina E, Williams L, et al
    Molecular analysis of HIV-1 infected individuals in a network-based intervention (TRIP): Phylogenetics identify HIV-1 infected individuals with social links.
    J Infect Dis. 2018 Apr 24. pii: 4984584. doi: 10.1093.
    >> Share

  37. HOSHINO A, Takashima T, Yoshida K, Morimoto A, et al
    Dysregulation of Epstein-Barr virus infection in hypomorphic ZAP70 mutation.
    J Infect Dis. 2018 Apr 19. pii: 4976509. doi: 10.1093.
    >> Share

    J Virol

  38. MARTIN JL, Mendonca L, Marusinec R, Zuczek J, et al
    Critical Role of the HTLV-1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly.
    J Virol. 2018 Apr 25. pii: JVI.00333-18. doi: 10.1128/JVI.00333.
    >> Share

    Lancet Infect Dis

  39. VARIAVA E, Martinson N
    Drug-resistant tuberculosis: the rise of the monos.
    Lancet Infect Dis. 2018 Apr 20. pii: S1473-3099(18)30247.
    >> Share

    N Engl J Med

  40. BACK DJ
    Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    N Engl J Med. 2018;378:1654-5.
    >> Share

    Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    N Engl J Med. 2018;378:1654.
    >> Share

  42. ROUGH K, Seage GR 3rd, Williams PL, Hernandez-Diaz S, et al
    Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.
    N Engl J Med. 2018;378:1593-1603.
    >> Share

  43. Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    N Engl J Med. 2018;378:1655-6.
    >> Share

    Nat Med

  44. COHN LB, da Silva IT, Valieris R, Huang AS, et al
    Clonal CD4(+) T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation.
    Nat Med. 2018 Apr 23. pii: 10.1038/s41591-018-0017.
    >> Share


  45. FLYNN PM
    A broader look at adolescents with perinatal HIV.
    Nature. 2018;556:439-440.
    >> Share

  46. LARSEN KP, Mathiharan YK, Kappel K, Coey AT, et al
    Architecture of an HIV-1 reverse transcriptase initiation complex.
    Nature. 2018 Apr 25. pii: 10.1038/s41586-018-0055.
    >> Share

    PLoS Comput Biol

  47. BYRNE CM, Gantt S, Coombs D
    Effects of spatiotemporal HSV-2 lesion dynamics and antiviral treatment on the risk of HIV-1 acquisition.
    PLoS Comput Biol. 2018;14:e1006129.
    >> Share

    PLoS One

  48. PENA LONGOBARDO LM, Oliva-Moreno J
    Differences in labour participation between people living with HIV and the general population: Results from Spain along the business cycle.
    PLoS One. 2018;13:e0195735.
    >> Share

  49. KOSTRIKIS LG, Hezka J, Stylianou DC, Kostaki E, et al
    HIV-1 transmission networks across Cyprus (2010-2012).
    PLoS One. 2018;13:e0195660.
    >> Share

  50. SCHATZ E, Knight L
    "I was referred from the other side": Gender and HIV testing among older South Africans living with HIV.
    PLoS One. 2018;13:e0196158.
    >> Share

  51. TURKOVA A, Moore CL, Butler K, Compagnucci A, et al
    Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial.
    PLoS One. 2018;13:e0196239.
    >> Share

  52. HAN HR, Kim K, Murphy J, Cudjoe J, et al
    Community health worker interventions to promote psychosocial outcomes among people living with HIV-A systematic review.
    PLoS One. 2018;13:e0194928.
    >> Share

  53. LOPEZ-RUZ MA, Lopez-Zuniga MA, Gonzalvo MC, Sampedro A, et al
    Effect of monotherapy with darunavir/cobicistat on viral load and semen quality of HIV-1 patients.
    PLoS One. 2018;13:e0196257.
    >> Share

  54. GARRETT NJ, Osman F, Maharaj B, Naicker N, et al
    Beyond syndromic management: Opportunities for diagnosis-based treatment of sexually transmitted infections in low- and middle-income countries.
    PLoS One. 2018;13:e0196209.
    >> Share

  55. DORAN RC, Tatsuno GP, O'Rourke SM, Yu B, et al
    Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies.
    PLoS One. 2018;13:e0196370.
    >> Share

  56. WEN Y, Trinh HV, Linton CE, Tani C, et al
    Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant.
    PLoS One. 2018;13:e0194266.
    >> Share

  57. LIBOIS A, Hallin M, Crucitti T, Delforge M, et al
    Prevalence of Mycoplasma genitalium in men with urethritis in a large public hospital in Brussels, Belgium: An observational, cross-sectional study.
    PLoS One. 2018;13:e0196217.
    >> Share

  58. FISHER KA, Cahill LM, Broyles S, Rorke M, et al
    Knowledge of hepatitis C status moderates the relationship between history of drug treatment and sterile syringe use.
    PLoS One. 2018;13:e0196157.
    >> Share

  59. BRADLEY ELP, Vidot DC, Gaul Z, Sutton MY, et al
    Acceptability of oral rapid HIV testing at dental clinics in communities with high HIV prevalence in South Florida.
    PLoS One. 2018;13:e0196323.
    >> Share

  60. PILGRIM N, Jani N, Mathur S, Kahabuka C, et al
    Provider perspectives on PrEP for adolescent girls and young women in Tanzania: The role of provider biases and quality of care.
    PLoS One. 2018;13:e0196280.
    >> Share

  61. MARITZ MF, Ray RM, Bick AJ, Tomasicchio M, et al
    Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels.
    PLoS One. 2018;13:e0196043.
    >> Share

  62. LUNAR MM, Zidovec Lepej S, Tomazic J, Vovko TD, et al
    HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.
    PLoS One. 2018;13:e0196670.
    >> Share

  63. CHEN M, Ma Y, Chen H, Dai J, et al
    HIV-1 genetic transmission networks among men who have sex with men in Kunming, China.
    PLoS One. 2018;13:e0196548.
    >> Share

  64. AKAPIRAT S, Karnasuta C, Vasan S, Rerks-Ngarm S, et al
    Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations.
    PLoS One. 2018;13:e0196397.
    >> Share

    PLoS Pathog

  65. LI Z, Mbonye U, Feng Z, Wang X, et al
    The KAT5-Acetyl-Histone4-Brd4 axis silences HIV-1 transcription and promotes viral latency.
    PLoS Pathog. 2018;14:e1007012.
    >> Share


  66. BOLIAR S, Patil S, Shukla BN, Ghobbeh A, et al
    Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier category.
    Virology. 2018;519:99-105.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016